<DOC>
	<DOCNO>NCT00000389</DOCNO>
	<brief_summary>The purpose study see effective treat child anxiety disorder fluvoxamine . Fluvoxamine successfully use treat obsessive-compulsive disorder ( OCD ) adults child . Anxiety disorder OCD , generalize anxiety disorder , social phobia , separation anxiety , common youth always responsive behavioral therapy alone . These disorder may respond fluvoxamine . A child evaluate 3 week he/she assign randomly ( like toss coin ) receive either fluvoxamine inactive placebo 8 week . After double-blind phase ( neither child/parents doctor know treatment give ) , child option continue treatment 4-month open-label extension period ( child/parents doctor know child receive ) . A child may eligible study he/she : Is 6 17 year old diagnose anxiety disorder ( i.e. , generalize anxiety disorder , social phobia , separation anxiety ) .</brief_summary>
	<brief_title>Treatment Anxiety Children</brief_title>
	<detailed_description>To evaluate fluvoxamine treatment child adolescent anxiety disorder . Fluvoxamine serotonin reuptake inhibitor FDA-approved treatment obsessive-compulsive disorder ( OCD ) adults child . Anxiety disorder OCD common youth always responsive psychosocial therapy . Fluvoxamine alternative treatment . After 3-week period evaluation , patient meet study entry criterion randomize receive either fluvoxamine placebo 8 week . After double-blind phase , patient enter 4-month open-label extension .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Anxiety , Separation</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Patients must : DSM IV diagnosis generalize anxiety disorder , social phobia , separation anxiety .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Adolescence</keyword>
	<keyword>Anxiety Disorders</keyword>
	<keyword>Child</keyword>
	<keyword>Female</keyword>
	<keyword>Fluvoxamine</keyword>
	<keyword>Human</keyword>
	<keyword>Male</keyword>
	<keyword>Serotonin Uptake Inhibitors</keyword>
	<keyword>Anxiety Disorders -- *drug therapy</keyword>
	<keyword>Fluvoxamine -- *therapeutic use</keyword>
	<keyword>Serotonin Uptake Inhibitors -- *therapeutic use</keyword>
</DOC>